VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $9,180,000 | +46.0% | 395,000 | 0.0% | 0.85% | +65.9% |
| Q1 2018 | $6,288,000 | -23.4% | 395,000 | 0.0% | 0.51% | -24.0% |
| Q4 2017 | $8,208,000 | +45.0% | 395,000 | 0.0% | 0.67% | +29.5% |
| Q3 2017 | $5,660,000 | -17.2% | 395,000 | 0.0% | 0.52% | -6.1% |
| Q2 2017 | $6,834,000 | +56.9% | 395,000 | 0.0% | 0.55% | +56.2% |
| Q1 2017 | $4,357,000 | -24.0% | 395,000 | 0.0% | 0.35% | -18.8% |
| Q4 2016 | $5,735,000 | -40.9% | 395,000 | 0.0% | 0.44% | -49.9% |
| Q3 2016 | $9,697,000 | +21.9% | 395,000 | 0.0% | 0.87% | +39.6% |
| Q2 2016 | $7,955,000 | -23.4% | 395,000 | 0.0% | 0.62% | -31.7% |
| Q1 2016 | $10,389,000 | -36.1% | 395,000 | +146.9% | 0.91% | -45.8% |
| Q4 2015 | $16,264,000 | – | 160,000 | – | 1.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |